Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
06/1995
06/28/1995EP0659419A1 2-Phenyl-3-azoylthiophenes for inhibiting breast disorders
06/28/1995EP0659417A2 Inhibition of dysfunctional uterine bleeding
06/28/1995EP0659413A2 Inhibition of CNS problems in post-menopausal women
06/28/1995EP0659412A2 Inhibition of the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder
06/28/1995EP0659411A2 Method for increasing libido in post-menopausal women
06/28/1995EP0659213A1 Growth hormone antagonists
06/28/1995EP0659182A1 Piperazine derivatives and salts thereof
06/27/1995US5428037 Heterocyclic derivatives in the treatment of Ischaemia and related diseases
06/27/1995CA1336048C Process for making flexographic plates with increased flexibility
06/22/1995WO1995016707A1 ANALOGUES OF hGH-RH (1-29)NH2 HAVING ANTAGONISTIC ACTIVITY
06/22/1995WO1995016672A1 Vitamin d amine and amide derivatives
06/22/1995WO1995016663A1 N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives as chelating agents
06/22/1995WO1995016466A1 Antisense oligonucleotides to suppress eicosanoid formation
06/22/1995WO1995016442A1 Novel potassium channel agonist produced from trichoderma virens
06/22/1995WO1995011048A3 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE IN VIVO OR $i(EX VIVO)
06/22/1995WO1995010271A3 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
06/22/1995DE4406332C1 Use of transdermal glyceryl tri:nitrate formulations in pregnancy
06/22/1995CA2179203A1 N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives as chelating agents
06/22/1995CA2179168A1 Antisense oligonucleotides to suppress eicosanoid formation
06/22/1995CA2179068A1 Novel potassium channel agonist produced from trichoderma virens
06/22/1995CA2178218A1 Analogues of hgh-rh (1-29)nh2 having antagonistic activity
06/22/1995CA2178090A1 Vitamin d amine and amide derivatives
06/22/1995CA2138638A1 Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them
06/22/1995CA2138513A1 Methods of inhibiting myeloperoxidase activity
06/22/1995CA2138511A1 Methods of inhibiting atrophy of the skin and vagina
06/22/1995CA2138510A1 Methods of inhibiting dysfunctional uterine bleeding
06/22/1995CA2138507A1 Methods of inhibiting sexual precocity
06/22/1995CA2138506A1 Methods of inhibiting male infertility
06/22/1995CA2138505A1 Methods of inhibiting the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder
06/22/1995CA2138501A1 Methods of inhibiting breast disorders
06/22/1995CA2138500A1 Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism
06/22/1995CA2138497A1 Method for increasing libido in post-menopausal women
06/22/1995CA2138494A1 Methods of inhibiting turner's syndrome
06/22/1995CA2138459A1 Methods of inhibiting cns problems in post-menopausal women
06/22/1995CA2138454A1 Methods of inhibiting imperfect tissue repair
06/22/1995CA2138100A1 Methods of treating menstrual symptoms and compositions therefor
06/21/1995EP0658169A1 Diamino acid derivatives as antihypertensives
06/20/1995US5426229 Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes, 3-aminochromanes, and 3-aminothiochromanes
06/20/1995US5426226 Intermediates for making ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes
06/20/1995US5426122 Methods for reducing blood pressure with dimercaptosuccinic acid (DMSA)
06/20/1995US5426103 Certain macrocyclic lactam derivatives
06/20/1995CA2017619C Use of naftopidil for the therapy of dysuria in cases of benign prostatic hypertrophy
06/15/1995WO1995016033A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY
06/15/1995WO1995015963A1 Bicyclene derivatives, their production and use
06/15/1995WO1995015957A1 Chroman derivative
06/15/1995WO1995015954A1 Heterocyclic biphenylylamides useful as 5ht1d antagonists
06/15/1995WO1995015951A1 Novel imidazole derivative and process for producing the same
06/15/1995WO1995015767A1 Long-acting injection suspensions and a process for their preparation
06/15/1995CA2176825A1 C5a receptor antagonists having substantially no agonist activity
06/14/1995EP0656786A1 Health supplements containing phyto-oestrogens, analogues or metabolites thereof
06/14/1995EP0656781A1 Composition comprising fertilized shell eggs
06/08/1995WO1995015339A1 Antagonists to chaperonin 10
06/08/1995WO1995015338A1 Chaperonin 10
06/08/1995WO1995015311A1 Tachykinin antagonists
06/08/1995WO1995015309A1 Dp-iv-serine protease inhibitors
06/08/1995WO1995015308A1 Crystalline, polymorphic form of (s,s,s)-n-(1-[2-carboxy-3-(n2-mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine
06/08/1995WO1995011309A3 A novel nuclear mitotic phosphoprotein: mitosin
06/08/1995CA2178066A1 Dp-iv-serine protease inhibitors
06/08/1995CA2177994A1 Tachykinin antagonists
06/07/1995EP0656208A2 Use of synthetic huminates for the manufacture of a medicament for the treatment of disease of the mucosa
06/07/1995EP0655916A1 Transdermal application agent containing 3-keto-desogestrel
06/07/1995EP0655914A1 Novel compositions
06/06/1995US5422371 Contacting a cell with a fatty acid or fatty alcohol to prevent reduction of testosterone to 5a-dihydrotestosterone
06/06/1995US5422359 α-aminoketone derivatives
06/06/1995US5422349 Renin inhibitors
06/01/1995WO1995014785A1 Composition for the in vivo production of therapeutic products
06/01/1995WO1995014682A1 Isoxazoline compounds useful as fibrinogen receptor antagonists
06/01/1995WO1995014673A1 4,5-diphenylimidazole derivatives, their preparation and their use as acyl coenzyme a: cholesterol-0-acyl-transferase (acat) inhibitor
06/01/1995CA2174415A1 Isoxazoline compounds useful as fibrinogen receptor antagonists
06/01/1995CA2154475A1 4,5-diphenylimidazole derivatives, their preparation and their use as acyl coenzyme a: cholesterol-0-acyl-transferase (acat) inhibitor
05/1995
05/31/1995EP0655461A1 Cyclic amino acid derivatives having ACE and NEP inhibiting activity
05/31/1995EP0655460A1 Pharmacotherapeutical use of glutathione derivatives
05/31/1995EP0655089A1 Effects of actin filaments on fibrin clot structure and lysis
05/31/1995EP0655063A1 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension
05/31/1995EP0655058A1 Pyridinyl/quinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/31/1995EP0655056A1 Piperidinyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension
05/31/1995EP0654994A1 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
05/31/1995CN1028655C NF-1616-904 oxide of pyrazine and medicine composition contained this compound
05/30/1995US5420138 Bicyclic pyridines which are angiotensin II inhibitors
05/30/1995US5420130 2-aminopyrazine-5-carboxamide derivatives, their preparation and their application in therapeutics
05/30/1995US5420111 Somatomedins, fetal growth promoters
05/30/1995CA2050303C Drugs (calcitonin gene-related peptides) for treating erectile dysfunctions
05/30/1995CA2016326C Pyrido-pyridazinone acetic acids for treating chronic diabetic complications
05/30/1995CA1335733C 1h-indazole-3-acetic acids as aldose reductase inhibitors
05/26/1995WO1995014095A1 Endothelin-converting enzyme
05/26/1995WO1995014085A2 A method for detection of alterations in the dna mismatch repair pathway
05/26/1995WO1995014025A1 Piperidinylcamphorsulfonyl oxytocin antagonists
05/26/1995WO1995013824A1 Method of treating renal disease by administering igf-i and igfbp-3
05/26/1995WO1995013821A1 αvβ3 INTEGRIN AS A PREDICTOR OF ENDOMETRIOSIS
05/26/1995WO1995013805A1 Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
05/26/1995WO1995013802A1 Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor
05/26/1995WO1995013800A1 Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors
05/26/1995CA2176819A1 A method for detection of alterations in the dna mismatch repair pathway
05/26/1995CA2176747A1 Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
05/26/1995CA2176727A1 Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors
05/26/1995CA2176721A1 Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor
05/26/1995CA2176709A1 Method of treating renal disease by administering igf-i and igfbp-3
05/26/1995CA2176507A1 Endothelin-converting enzyme
05/26/1995CA2174650A1 Piperidinyl camphorsulfonyl oxytocin antagonists
05/24/1995EP0654265A1 Aromatase-inhibiting composition containing azole derivative
1 ... 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 ... 557